Thursday October 8, 2026

ARPA-H’s DELPHI program is developing next-generation biosensor technology that could continuously monitor biological signals such as hormones, inflammation markers, nutrients, and medication levels, potentially giving people and healthcare providers a much more detailed real-time picture of what’s happening inside the body. It’s currently research technology rather than a consumer product.